Angela Hall
Senior Director, Consulting, SAS
Angela Hall leads a team of architects at SAS Institute Inc. who implement analytic focused solutions that uncover hidden patterns to make improvements such as eliminating waste and fraud. A SAS user since 1995, Angela enjoys working with OLAP data structures and developing custom applications using stored processes. She received a BS in statistics from N.C. State University and an MBA with an emphasis in technology management from the University of Phoenix. A previous chair of the American Society of Quality’s Raleigh, North Carolina, chapter, she has also co-chaired a Southeast SAS Users Group (SESUG) section and continues to present papers at SAS Global Forum conferences.
By This Author
Building Business Intelligence Using SAS®: Content Development Examples
By Tricia Aanderud and Angela Hall
Focusing on the SAS BI client, the authors provide a quick-start guide loaded with examples and tips that will help users move quickly from using only one BI client tool to using a significant portion of the system.
*This book is out of print.
Featured Authors
-
Robert N. Rodriguez retired from SAS in 2018 after serving as a senior director in research and development. Bob received a PhD in statistics from the University of North Carolina at Chapel Hill and was a research statistician at General Motors Research Laboratories before joining SAS.
-
Terisa Roberts is a director and Global Solution lead for Risk Modeling and Decisioning at SAS. She has extensive experience in quantitative risk management, regulatory compliance, and model governance and validation. She has worked in financial services, telecommunications, government, energy, and retail sectors.
-
Ron Klimberg, PhD, is a professor at the Haub School of Business at Saint Joseph's University in Philadelphia, PA.
-
Todd Case has been working in the pharmaceutical industry as a statistical programmer for over 20 years. He completed his MS in Epidemiology from Columbia University and has worked at Forest Laboratories (now Allergan), Genentech, Bristol-Myers Squibb, and Biogen. He currently works at Vertex Pharmaceuticals.